The National Academy of Medicine has elected 100 new members, including 19 cancer leaders and researchers from institutions across the U.S.
The new class includes 90 regular members and 10 international members, bringing the academy’s total membership to more than 2,600, according to an Oct. 19 news release.
New members are chosen by current members based on their contributions to medical science, healthcare and public health, the release said.
Here are the 19 cancer leaders and researchers elected to the National Academy of Medicine in 2026:
- Cory Abate-Shen, PhD, chair of molecular pharmacology and therapeutics at New York City-based Columbia University’s Vagelos College of Physicians and Surgeons
- Kathleen Burns, MD, PhD, chair of pathology at Boston-based Dana-Farber Cancer Institute
- Frédéric de Sauvage, PhD, vice president of research oncology at South San Francisco, Calif.-based Genentech
- Marcela del Carmen, MD, president of Boston-based Massachusetts General Hospital and the Massachusetts General Physician Organization
- Diane Harper, MD, professor of family medicine and obstetrics and gynecology at Ann Arbor-based University of Michigan
- Roy Herbst, MD, PhD, director of Lebanon, N.H.-based Dartmouth Cancer Center
- Jacqueline Jeruss, MD, PhD, research professor of surgical oncology and associate vice president for research integrity and compliance at Ann Arbor-based University of Michigan
- Nancy Keating, MD, professor of healthcare policy and medicine at Boston-based Harvard Medical School
- Albert Koong, MD, PhD, senior vice president and chief scientific officer at Houston-based University of Texas MD Anderson Cancer Center
- Maciej Lesniak, MD, chair of neurological surgery at Chicago-based Northwestern University Feinberg School of Medicine
- Anthony Letai, MD, PhD, director of the Bethesda, Md.-based National Cancer Institute
- Ross Levine, MD, chief scientific officer of the department of medicine at New York City-based Memorial Sloan Kettering Cancer Center
- Dana Pe’er, PhD, chair of the computational and systems biology program at New York City-based Memorial Sloan Kettering Cancer Center’s Sloan Kettering Institute
- Katy Rezvani, MD, PhD, professor of stem cell transplantation at Houston-based University of Texas MD Anderson Cancer Center
- Charles Roberts, MD, PhD, president and CEO-elect of Memphis, Tenn.-based St. Jude Children’s Research Hospital
- Ali Shilatifard, PhD, chair of biochemistry and molecular genetics at Chicago-based Northwestern University Feinberg School of Medicine
- Dennis Slamon, MD, PhD, chief of hematology and oncology at University of California Los Angeles’ David Geffen School of Medicine and director of clinical and translational research at the UCLA Jonsson Comprehensive Cancer Center
- Kimberly Stegmaier, MD, chair of pediatric oncology at Boston-based Dana-Farber Cancer Institute
- Elizabeth Swisher, MD, deputy director of Seattle-based Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
